0001593968-22-001522.txt : 20221013 0001593968-22-001522.hdr.sgml : 20221013 20221013060259 ACCESSION NUMBER: 0001593968-22-001522 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221010 FILED AS OF DATE: 20221013 DATE AS OF CHANGE: 20221013 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vanhove Geertrui CENTRAL INDEX KEY: 0001771994 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39635 FILM NUMBER: 221308018 MAIL ADDRESS: STREET 1: 1333 S. SPECTRUM BLVD #100 CITY: CHANDLER STATE: AZ ZIP: 85286 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Surrozen, Inc./DE CENTRAL INDEX KEY: 0001824893 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 981556622 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 171 OYSTER POINT BLVD STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-475-2820 MAIL ADDRESS: STREET 1: 171 OYSTER POINT BLVD STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Consonance-HFW Acquisition Corp. DATE OF NAME CHANGE: 20200915 4 1 primary_01.xml PRIMARY DOCUMENT X0306 4 2022-10-10 0001824893 Surrozen, Inc./DE SRZN 0001771994 Vanhove Geertrui C/O SURROZEN, INC. 171 OYSTER POINT BLVD., SUITE 400 SOUTH SAN FRANCISCO CA 94080 false true false false Chief Medical Officer Option (right to buy) 10.77 2022-10-10 4 D false 24587 D 2021-02-01 2031-02-22 Common Stock 24587 0 D Option (right to buy) 10.25 2022-10-10 4 D false 10427 D 2022-08-12 2031-08-12 Common Stock 10427 0 D Option (right to buy) 10.25 2022-10-10 4 D false 26220 D 2022-08-12 2031-08-12 Common Stock 26220 0 D Option (right to buy) 10.77 2022-10-10 4 D false 1760 D 2021-02-01 2031-02-22 Common Stock 1760 0 D Option (right to buy) 2.16 2022-10-10 4 A false 26220 A 2022-08-12 2031-08-12 Common Stock 26220 26220 D Option (right to buy) 2.16 2022-10-10 4 A false 10427 A 2022-08-12 2031-08-12 Common Stock 10427 10427 D Option (right to buy) 2.16 2022-10-10 4 A false 24587 A 2021-02-01 2031-02-22 Common Stock 24587 24587 D Option (right to buy) 2.16 2022-10-10 4 A false 1760 A 2021-02-01 2031-02-22 Common Stock 1760 1760 D The reporting person agreed to cancellation of an option granted to her on 2/23/2021, in exchange for a new option having a lower exercise price. The shares subject to the options vest and become exercisable in a series of 48 equal monthly installments beginning on 2/1/2021, subject to the reporting person's continued employment through the applicable vesting date. The reporting person agreed to cancellation of an option granted to her on 8/12/2021, in exchange for a new option having a lower exercise price. Twenty-five percent of the shares subject to the Stock Option vests on 8/12/2022, and the remainder vests in 36 equal monthly installments thereafter for the following three years. /s/Sheela Mohan-Peterson, Attorney-in-Fact for Geertrui Vanhove 2022-10-12